Search Results

The Bio-Mini Revo Suture Anchor is intended to reattach soft tissue to bone in arthroscopic or open surgical procedures. After the suture is anchored to the bone, it may be used to secure soft tissue, such as ligaments, tendons, or joint capsules, to the bone, thereby stabilizing the damaged area during the healing period.

The Linvatec Bio-Mini-Revo™ suture anchor is a bioabsorbale screw-in suture anchor that is preloaded on a disposable inserter device with one non-absorbable, braided, ultrahigh molecular weight polyethylene suture. The Bio-Mini-Revo™ suture anchor is manufactured from Self-Reinforced (96/4D) PLA Copolymer. The Copolymer is inert, non-collagenous and non-pyrogenic through the absorption process. The device will be available in two versions; with or without colorant D&C violet #2.

The requested information is not available in the provided document. The document is a 510(k) summary for a medical device (Bio-Mini Revo Suture Anchor) and primarily discusses its substantial equivalence to predicate devices, device description, and intended use. It does not contain details about specific acceptance criteria or a study proving the device meets them in the way described in the request (e.g., performance metrics, sample sizes, expert involvement, and ground truth establishment). The document is a regulatory submission for premarket notification, not a clinical or performance study report.

Ask a specific question about this device

Duet™ and Impact™ Suture Anchors are intended for use to reattach soft tissue to bone in orthopaedic surgical procedures. The device may be used in either arthroscopic or open surgical procedures. After the suture is anchored to the bone, it may be used to reattach soft tissue, such as ligaments, tendons, or joint capsules, to the bone. The suture anchor system thereby stabilizes the damaged soft tissue, in conjunction with appropriate postoperative immobilization, throughout the healing period.

The Duet™ and Impact™ Suture Anchors are contraindicated in 1) Surgical procedures other than those listed, 2) Conditions that may compromise Anchor fixation (osteopenic, comminuted bone, pathologic conditions in the soft tissues to be attached, etc., 3) Conditions that may retard healing (poor blood supply, past or potential infection, etc), 4) Active infection, 5) Conditions that may limit the patients ability or willingness to restrict activities or follow directions during the healing period, 6) Foreign body sensitivity to materials, 7) Patients with suspected or known allergy with implant or suture materials.

Duet™ Suture Anchor and Impact™ Suture Anchors are bioabsorbale suture anchors that are preloaded on a disposable inserter device with two non-absorbable sutures. Originally they were preloaded with non-absorbable, braided, polyester #2 sutures, one of them is green and another one is white.

Purpose of this special 510(k) premarket notification is amendment of new preloaded suture material into Duet™ and Impact™ suture anchor product lines. The new suture, Herculine is non-absorbable, braided, ultra-high molecular weight polyethylene #2 suture. In coloured version 2 filaments are replaced by blue polypropylene monofilaments Herculine suture meets USP requirements for knot tensile strength and needle attachment strength.

The provided text is a 510(k) summary for a medical device (Duet™ and Impact™ Suture Anchor) and a letter from the FDA regarding its clearance. It does not contain information about acceptance criteria, device performance, study design details (sample size, data provenance, expert consensus, adjudication, MRMC, or standalone studies), or ground truth establishment for either training or test sets.

The document primarily describes a special 510(k) premarket notification for an amendment to the existing suture anchors, specifically changing the preloaded suture material from polyester to ultra-high molecular weight polyethylene (Herculine). The core argument for substantial equivalence is that this change has no effect on the intended use, principles of operation, production, raw materials, or sterilization of the device, and that the new suture meets USP requirements for knot tensile strength and needle attachment strength.

Therefore, I cannot fulfill the request to provide a table of acceptance criteria and reported device performance or details about the study that proves the device meets the acceptance criteria, as this information is not present in the given text.

The text focuses on demonstrating substantial equivalence to a predicate device based on material change and compliance with general standards rather than presenting a performance study against specific acceptance criteria.

Ask a specific question about this device